Skip to main content
Premium Trial:

Request an Annual Quote

Sean Eddy, Joel Campbell, David Fullerton, David Barker, Mike Gresser

Premium
The Bioinformatics Organization has named Sean Eddy as the recipient of the 2007 Benjamin Franklin Award in the Life Sciences, which is presented annually to an individual “who has, in his or her practice, promoted free and open access to the materials and methods used in the life sciences.”
 
Eddy, a group leader at the Howard Hughes Medical Institute’s Janelia Farm Research Campus, is being recognized for his contributions to open source bioinformatics development, including the development of the HMMer protein sequence analysis package and the Pfam database of protein domains and families.
 
This year’s award will be presented at the 2007 Bioinformatics.Org Annual Meeting, held at the Bio-IT World Conference & Expo in Boston, Mass., April 30 - May 2.
 

 
Definiens has named Joel Campbell as vice president and general manager for its US operations and David Fullerton as vice president of worldwide professional services.
 
Campbell joins the firm from the Environmental Systems Research Institute, where he was director of US sales. Fullerton was in charge of professional services at Documentum and also held several marketing and services roles with Hewlett-Packard.
 

 
David Barker, who recently retired as vice president and chief scientific officer of Illumina, has joined NextBio’s board of directors. Barker joined Illumina in March 2000. Prior to that, he was vice president and chief science advisor at Amersham Biosciences (now GE Healthcare) and vice president of research and business development at Molecular Dynamics, which was acquired by Amersham.
 

 
Mike Gresser has joined the scientific advisory board of Oxford Genome Sciences. Gresser is currently a visiting scholar at the Molecular Biology Institute at the University of California, Los Angeles. Gresser previously worked at Amgen, where he was vice president of research for inflammation and head of neuroscience research. Before joining Amgen, Gresser worked at the Merck Frost Center for Therapeutic Research as executive director of biochemistry and molecular biology.

Filed under

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.